Velcade and anaemia Patient Reports February 11, 2012

Velcade Side Effects Report #4810896-7
Velcade side effect was reported by a Physician from UNITED STATES on Oct 10, 2005. Female patient, 54 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, back pain , erythema, mouth ulceration, neck pain, pain in extremity, pyrexia. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS; 1.00 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with BACTRIM, ZOMETA. Patient recovered.

Velcade Side Effects Report #4882552-0
Velcade side effect was reported by a Physician from UNITED STATES on Dec 29, 2005. Female patient, 54 years of age, was diagnosed with waldenstrom's macroglobulinaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, infection , mouth ulceration, pyrexia, rash , syncope, thrombocytopenia, vasculitis . Velcade dosage: unknown. During the same period patient was treated with BACTRIM, ZOMETA. Patient recovered.

Velcade Side Effects Report #5429387-8
Velcade side effect was reported by a Physician from FRANCE on Aug 13, 2007. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain upper, abdominal rigidity, anaemia, c-reactive protein increased, condition aggravated, cough, disease progression, epistaxis, febrile neutropenia. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXIL, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5552343-6
Velcade side effect was reported by a Physician from FRANCE on Nov 27, 2007. Male patient, 59 years of age, weighting 65.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, cough, disease progression, febrile neutropenia, histiocytosis haematophagic, lymphoma , pulmonary haemorrhage, splenomegaly. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with VINCRISTINE, DOXIL, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN. Patient was hospitalized. Patient died on 06/03/2006.


Velcade Side Effects Report #5746206-0
Velcade side effect was reported by a Physician from FRANCE on May 06, 2008. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, disease progression, febrile neutropenia, haemoglobin decreased, histiocytosis haematophagic, leukopenia, lymphoma , pulmonary haemorrhage. Velcade dosage: 2.76 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN SULPHATE, GRANOCYTE, ELDISINE. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #6065156-6
Velcade side effect was reported by a Physician from FRANCE on Jan 20, 2009. Male patient, 59 years of age, weighting 143.3 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, condition aggravated, febrile neutropenia, histiocytosis haematophagic, lymphoma , pulmonary haemorrhage, renal failure acute, splenomegaly, thrombocytopenia. Velcade dosage: 2.76 MG UNK INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, METHOTREXATE, PREDNISONE, BLEOMYCIN SULPHATE, GRANOCYTE, ELDISINE. Patient was hospitalized. Patient died on 06/03/2006.

Velcade Side Effects Report #5468239-4
Velcade side effect was reported by a Physician from FRANCE on Sept 12, 2007. Female patient, 56 years of age, weighting 103.6 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, dysphagia, hiatus hernia, oesophagitis ulcerative, oral candidiasis, thrombocytopenia. Velcade dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, METHOTREXATE, MESNA, GRANOCYTE, VALACYCLOVIR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5570122-0
Velcade side effect was reported by a Physician from FRANCE on Dec 06, 2007. Female patient, 56 years of age, weighting 103.6 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, aphthous stomatitis, dysphagia, febrile bone marrow aplasia, laboratory test interference, odynophagia, oesophageal candidiasis, oral candidiasis. Velcade dosage: unknown. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, METHOTREXATE, PREDNISONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5746203-5
Velcade side effect was reported by a Physician from FRANCE on May 06, 2008. Female patient, 56 years of age, weighting 103.6 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, dysphagia, hiatus hernia, mucous membrane disorder, oesophageal candidiasis, oesophageal ulcer, oral candidiasis, pancytopenia, thrombocytopenia. Velcade dosage: 2.40 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN SULPHATE, METHOTREXATE, GRANOCYTE, UROMITEXAN, VALACYCLOVIR. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5424476-6
Velcade side effect was reported by a Physician from FRANCE on Aug 13, 2007. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, dysphagia, febrile neutropenia, oesophagitis, thrombocytopenia. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, GRANOCYTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5744894-6
Velcade side effect was reported by a Physician from FRANCE on May 06, 2008. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, febrile neutropenia, mucosal inflammation, oesophagitis, thrombocytopenia. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with ADRIBLASTINE, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN SULPHATE, GRANOCYTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4998489-2
Velcade side effect was reported by a Physician from FRANCE on Apr 25, 2006. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, febrile bone marrow aplasia, oesophagitis, thrombocytopenia. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5013908-3
Velcade side effect was reported by a Physician from FRANCE on May 17, 2006. Female patient, 54 years of age, weighting 97.00 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aplasia, diarrhoea, febrile neutropenia, mucosal inflammation, oesophagitis, thrombocytopenia. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with ADRIABLASTINE, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, GRANOCYTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5391749-5
Velcade side effect was reported by a Physician from FRANCE on July 06, 2007. Male patient, 43 years of age, weighting 152.1 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aplasia. Velcade dosage: 2.80 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, METHOTREXATE. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5411250-X
Velcade side effect was reported by a Physician from FRANCE on July 27, 2007. Male patient, 43 years of age, weighting 152.1 lb, was diagnosed with t-cell lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, pancytopenia. Velcade dosage: 2.80 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, CYCLOPHOSPHAMIDE, ELDISINE, BLEOMYCIN, METHOTREXATE BELLON, GRANOCYTE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5392965-9
Velcade side effect was reported by a Physician from UNITED STATES on July 09, 2007. Female patient, 36 years of age, weighting 68.34 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arterial injury, cerebral ischaemia, cerebrovascular accident, gastrointestinal haemorrhage, hypokalaemia, hyponatraemia. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5401214-4
Velcade side effect was reported by a Physician from UNITED STATES on July 20, 2007. Female patient, 36 years of age, weighting 68.34 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arterial injury, cerebral ischaemia, embolism, facial paresis, foreign body trauma, gastrointestinal haemorrhage, hemiparesis, hypokalaemia. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN, PERCOCET, OXYCODONE, ACETAMINOPHEN, GABAPENTIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5409038-9
Velcade side effect was reported by a Physician from UNITED STATES on July 26, 2007. Female patient, 36 years of age, weighting 68.34 lb, was diagnosed with squamous cell carcinoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arterial injury, arthropod infestation, bacteria stool identified, cerebral ischaemia, cerebrovascular accident, disease progression, embolism, facial paresis. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with IRINOTECAN, PERCOCET, OXYCODONE, ACETAMINOPHEN, GABAPENTIN. Patient was hospitalized. Patient died on 07/20/2007.

Velcade Side Effects Report #6090771-3
Velcade side effect was reported by a Physician from UNITED STATES on Feb 11, 2009. Male patient, 65 years of age, weighting 229.7 lb, was diagnosed with non-small cell lung cancer and was treated with Velcade. After drug was administered, patient experienced the following side effects: adhesion , anaemia, atrial fibrillation , blood potassium increased, bronchial secretion retention, cardiac failure congestive, colitis, hypoalbuminaemia, hyponatraemia. Velcade dosage: 1 MG/M2. During the same period patient was treated with TAXOTERE, CARBOPLATIN, COUMADIN, CARDIZEM CD, HYDROCHLOROTHIAZIDE, LISINOPRIL. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #4587474-0
Velcade side effect was reported by a Physician from on Jan 25, 2005. Male patient, 63 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, disease progression, dyspnoea, hypotension, neutropenia, pneumonia , productive cough, renal failure acute, respiratory failure. Velcade dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient died on 12/22/2004.

Velcade Side Effects Report #4634789-3
Velcade side effect was reported by a Physician from on Mar 31, 2005. Male patient, 63 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: agitation, anaemia, ascites, blood albumin decreased, blood ph decreased, blood pressure immeasurable, coma, disease progression, hepatosplenomegaly. Velcade dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient was hospitalized. Patient died on 12/22/2004.

Velcade Side Effects Report #4780255-4
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 07, 2005. Male patient, 48 years of age, weighting 180.3 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , bile duct obstruction, catheter site cellulitis, diarrhoea, febrile neutropenia, hypokalaemia, hypomagnesaemia, hypotension. Velcade dosage: unknown. During the same period patient was treated with RITUXAN, CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISONE, MORPHINE, PROPRANOLOL, REGLAN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5318495-8
Velcade side effect was reported by a Physician from ITALY on Apr 20, 2007. Male patient, 67 years of age, weighting 74.00 lb, was diagnosed with myelofibrosis and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, chronic obstructive pulmonary disease, fluid retention, hepatosplenomegaly, oedema peripheral, oxygen saturation decreased, pleural effusion, pulmonary congestion, thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, ACETYLCYSTEINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5914432-3
Velcade side effect was reported by a Physician from UNITED STATES on Sept 25, 2008. Female patient was diagnosed with myelofibrosis and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, fatigue, gastrointestinal disorder, hyponatraemia, monocytosis, oesophageal varices haemorrhage, pain , pneumonitis, thrombocytopenia. Velcade dosage: 1.6 MG/M2 INTRAVENOUS. Patient recovered.


Velcade Side Effects Report #5354877-6
Velcade side effect was reported by a Physician from UNITED STATES on May 31, 2007. Male patient, 71 years of age, weighting 183.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , blood creatinine increased, cellulitis , febrile neutropenia, groin abscess, groin pain, thrombocytopenia. Velcade dosage: 1.50 MG/M2, INTRAVENOUS. During the same period patient was treated with TYLENOL, CARVEDILOL, VICODIN, COLACE, DOXAZOSIN, ESOMEPRAZOLE, NITROGLYCERIN, HYDROXIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5678780-7
Velcade side effect was reported by a Physician from UNITED STATES on Mar 11, 2008. Male patient, 86 years of age, weighting 164.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arthritis bacterial, cellulitis , chondrocalcinosis pyrophosphate, deep vein thrombosis , erythema, faecal incontinence, gout , international normalised ratio increased. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with REVLIMID, DEXAMETHASONE, COUMADIN, ACYCLOVIR, ASPIRIN, CARDURA, COLACE, LASIX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5691687-4
Velcade side effect was reported by a Physician from UNITED STATES on Mar 25, 2008. Male patient, 86 years of age, weighting 164.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arthritis bacterial, cellulitis , chondrocalcinosis pyrophosphate, deep vein thrombosis , erythema, faecal incontinence, gait disturbance, gout . Velcade dosage: 1.30 MG/M2. During the same period patient was treated with REVLIMID, DEXAMETHASONE, COUMADIN, ACYCLOVIR, ASPIRIN, CARDURA, COLACE, LASIX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5758030-3
Velcade side effect was reported by a Physician from UNITED STATES on May 20, 2008. Male patient, 86 years of age, weighting 164.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arthritis bacterial, cellulitis , chondrocalcinosis pyrophosphate, deep vein thrombosis , faecal incontinence, gout , international normalised ratio increased, prostatic specific antigen increased. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with REVLIMID, DEXAMETHASONE, COUMADIN, ACYCLOVIR, ASPIRIN, CARDURA, COLACE, LASIX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5330620-1
Velcade side effect was reported by a Physician from GERMANY on May 04, 2007. Male patient, 83 years of age, weighting 167.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aortic elongation, aortic valve incompetence, atrioventricular block first degree, bladder disorder, bone disorder, bundle branch block right, cholelithiasis, electrocardiogram abnormal. Velcade dosage: 1.00 MG, INTRAVENOUS. During the same period patient was treated with KEVATRIL. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5191315-0
Velcade side effect was reported by a Physician from GERMANY on Dec 06, 2006. Male patient, 83 years of age, weighting 1676 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acquired immunodeficiency syndrome, anaemia, aortic elongation, atrioventricular block first degree, bone disorder, bundle branch block right, heart valve insufficiency, hypertension, oedema peripheral. Velcade dosage: 1.00 MG, INTRAVENOUS. During the same period patient was treated with KEVATRIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5126344-6
Velcade side effect was reported by a Physician from UNITED STATES on Sept 27, 2006. Female patient, 82 years of age, weighting 143.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , brain natriuretic peptide increased, diastolic dysfunction, fibrin d dimer increased, respiratory distress. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ALTACE, DARVOCET, NEURONTIN, LORTAB, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5127196-0
Velcade side effect was reported by a Physician from UNITED STATES on Sept 27, 2006. Female patient, 82 years of age, weighting 136.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, atrial fibrillation , diastolic dysfunction, flank pain, hypotension, lung infiltration, pneumonia , pneumonitis. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with BETAPACE, ALTACE, ASPIRIN, NEURONTIN, ZOLOFT, FOLIC ACID, DARVOCET. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5169048-6
Velcade side effect was reported by a Physician from UNITED STATES on Nov 21, 2006. Female patient, 82 years of age, weighting 143.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, anaemia, aortic valve disease, asthenia, atrial fibrillation , atrial flutter, blood ph decreased, blood pressure increased, brain natriuretic peptide increased. Velcade dosage: 1.00 MG/M2, INTRAVENOUS. During the same period patient was treated with ALTACE, DARVOCET, NEURONTIN, LORTAB, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5914604-8
Velcade side effect was reported by a Physician from UNITED STATES on Sept 26, 2008. Male patient, 81 years of age, weighting 179.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia. Velcade dosage: 2.6 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FAMVIR, ASPIRIN. Patient died on 09/17/2008.


Velcade Side Effects Report #4553033-9
Velcade side effect was reported by a Physician from on Dec 28, 2004. Female patient, 81 years of age, weighting 139.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aortic valve incompetence, cardiac failure congestive, cardiomegaly, contusion, dilatation ventricular, dizziness , ejection fraction decreased, mitral valve incompetence. Velcade dosage: 2.10 MG, IV BOLUS. During the same period patient was treated with OXYCONTIN, VITAMIN E, VITAMIN C, OCUPRESS, XALATAN, SENOKOT, MEGACE, AMITRIPTYLINE. Patient recovered.

Velcade Side Effects Report #5872515-0
Velcade side effect was reported by a Consumer or non-health professional from RUSSIAN FEDERATION on Aug 26, 2008. Male patient, 80 years of age, weighting 132.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia. Velcade dosage: 1.7 MG. Patient died on 02/09/2008.

Velcade Side Effects Report #6027964-7
Velcade side effect was reported by a Physician from JAPAN on Dec 15, 2008. Female patient, 80 years of age, weighting 85.98 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute myocardial infarction, anaemia, angina pectoris, coronary artery stenosis, myocardial ischaemia. Velcade dosage: 0.7 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, ISOSORBIDE DINITRATE, PURSENNID, MAGNESIUM OXIDE, FOLIC ACID, ZANTAC, DIFLUCAN. Patient recovered.

Velcade Side Effects Report #5232404-1
Velcade side effect was reported by a Physician from JAPAN on Jan 26, 2007. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, aspergillosis, blood albumin decreased, blood bilirubin increased, blood urea increased, dehydration, ecchymosis, enterococcal infection. Velcade dosage: 1.88 MG,. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, FLIVAS, CLINORIL, ALFAROL, METHYCOBAL, FOLIC ACID, CALCIUM LACTATE. Patient recovered.

Velcade Side Effects Report #5261526-4
Velcade side effect was reported by a Physician from JAPAN on Feb 19, 2007. Male patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, aspergillosis, blood albumin decreased, blood bilirubin increased, blood urea increased, condition aggravated, dehydration, ecchymosis. Velcade dosage: 1.88 MG. During the same period patient was treated with DEXAMETHASONE, FAMOTIDINE, FLIVAS, CLINORIL, ALFAROL, METHYCOBAL, FOLIC ACID, CALCIUM LACTATE. Patient died on 02/18/2007.


Velcade Side Effects Report #5313772-9
Velcade side effect was reported by a Physician from AUSTRALIA on Apr 17, 2007. Female patient, 78 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cerebral haemorrhage. Velcade dosage: 2.30 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, ROMIDEPSIN. Patient recovered.

Velcade Side Effects Report #5361069-3
Velcade side effect was reported by a Physician from UNITED STATES on May 31, 2007. Female patient, 78 years of age, weighting 172.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, brain natriuretic peptide increased, cardiac failure congestive, cardiotoxicity, compression fracture, condition aggravated, epistaxis, hypotension. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with DOXIL, PALONOSETRON, DEXAMETHASONE, PROCHLORPERAZINE MALEATE, COMPAZINE, COUMADIN, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5382080-2
Velcade side effect was reported by a Physician from UNITED STATES on June 21, 2007. Female patient, 78 years of age, weighting 172.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atelectasis, cardiac failure congestive, cardiotoxicity, compression fracture, condition aggravated, coronary artery disease , epistaxis. Velcade dosage: unknown. During the same period patient was treated with DOXIL, PALONOSETRON, DEXAMETHASONE, PROCHLORPERAZINE MALEATE, COMPAZINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5384677-2
Velcade side effect was reported by a Physician from UNITED STATES on May 11, 2007. Female patient, 78 years of age, weighting 172.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, epistaxis, hypotension, renal failure acute, respiratory failure, skin lesion. Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with DOXIL, PALONOSETRON, DEXAMETHASONE, PROCHLORPERAZINE MALEATE, COMPAZINE, COUMADIN, ASPIRIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5398452-6
Velcade side effect was reported by a Physician from UNITED STATES on July 13, 2007. Female patient, 78 years of age, weighting 172.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atelectasis, atrial fibrillation , blood potassium decreased, blood pressure systolic decreased, brain natriuretic peptide increased, cardiac failure congestive, chronic obstructive pulmonary disease, coronary artery disease . Velcade dosage: 1.30 MG/M2, IV BOLUS. During the same period patient was treated with DOXIL, PALONOSETRON, DEXAMETHASONE, PROCHLORPERAZINE MALEATE, COMPAZINE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5984815-4
Velcade side effect was reported by a Physician from JAPAN on Nov 20, 2008. Male patient, 78 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood cholinesterase decreased, blood lactate dehydrogenase increased, disease progression, gastrointestinal haemorrhage, hyperkalaemia, hypotension. Velcade dosage: 1.5 MG, INTRAVENOUS. During the same period patient was treated with CANDESARTAN CILEXETIL, ALLOPURINOL, KAYEXALATE, MOBIC, METHYCOBAL, PURSENNID, OXYCONTIN, MAGNESIUM OXIDE. Patient died on 10/15/2008.

Velcade Side Effects Report #4614369-6
Velcade side effect was reported by a Physician from on Dec 29, 2004. Male patient, 78 years of age, weighting 134.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: amnesia, anaemia, fatigue, neuropathy peripheral, white blood cell count decreased. Velcade dosage: unknown. During the same period patient was treated with OXYCODONE, CLODRONATE DI. Patient recovered.

Velcade Side Effects Report #5694197-3
Velcade side effect was reported by a Physician from JAPAN on Mar 21, 2008. Female patient, 77 years of age, weighting 92.59 lb, was diagnosed with multiple myeloma , pneumonia fungal, hyponatraemia, prophylaxis and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, constipation , diarrhoea, hepatic function abnormal, herpes zoster, hyponatraemia, lymphocyte count decreased, neurogenic bladder, platelet count decreased. Velcade dosage: 1.70 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, FUNGUARD, VORICONAZOLE, ITRACONAZOLE, HYDROCORTONE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, CLARITHROMYCIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5708421-1
Velcade side effect was reported by a Physician from JAPAN on Apr 03, 2008. Male patient, 77 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, platelet count decreased, pleural effusion, pneumonia , rash . Velcade dosage: 2.00 MG, INTRAVENOUS : 1.5 MG, INTRAVENOUS. During the same period patient was treated with ROCEPHIN, ALLOPURINOL, PURSENNID, AMLODIPINE BESYLATE, DIOVANE, ROHYPNOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5728567-1
Velcade side effect was reported by a Physician from JAPAN on Apr 21, 2008. Male patient, 77 years of age, weighting 134.5 lb, was diagnosed with multiple myeloma , pneumonia  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, laryngeal cancer, platelet count decreased, pleural effusion, pneumonia , pyrexia, rash , white blood cell count decreased. Velcade dosage: 2.00 MG, INTRAVENOUS; 1.5 MG, INTRAVENOUS. During the same period patient was treated with ROCEPHIN, ALLOPURINOL, PURSENNID, AMLODIPINE BESYLATE, DIOVANE, ROHYPNOL. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5921280-7
Velcade side effect was reported by a Physician from JAPAN on Sept 30, 2008. Female patient, 77 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase decreased. Velcade dosage: unknown. Patient recovered.

Velcade Side Effects Report #5951504-1
Velcade side effect was reported by a Physician from JAPAN on Oct 27, 2008. Female patient, 77 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase decreased, blood lactate dehydrogenase decreased. Velcade dosage: unknown. Patient died on 10/15/2008.

Velcade Side Effects Report #4778188-2
Velcade side effect was reported by a Health Professional from UNITED STATES on Sept 07, 2005. Male patient, 77 years of age, weighting 159.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, aspartate aminotransferase increased, blood albumin decreased, blood bilirubin increased, blood calcium decreased, blood chloride decreased, blood potassium increased, brain natriuretic peptide increased, cardiac failure congestive. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with CRESTOR, LOTENSIN, INSULIN, IRON, DURAGESIC, PROTONIX, MOBIC, VITAMIN C. Patient was hospitalized. Patient died on 08/26/2005.

Velcade Side Effects Report #4830539-6
Velcade side effect was reported by a Physician from UNITED STATES on Oct 31, 2005. Female patient, 77 years of age, weighting 124.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal adhesions, anaemia, ascites, biliary dilatation, colitis, diverticulitis, hiatus hernia, hypocalcaemia, hypokalaemia. Velcade dosage: unknown. During the same period patient was treated with THALIDOMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5678125-2
Velcade side effect was reported by a Physician from JAPAN on Mar 07, 2008. Female patient, 76 years of age, weighting 119.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, bedridden, catheter related complication, deep vein thrombosis , disease progression, neuropathy peripheral, oedema peripheral, pulmonary embolism , tumour lysis syndrome. Velcade dosage: 1.90 MG, INTRAVENOUS; 1.50 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, DEXAMETHASONE PHOSPHATE, LASIX, PIPERACILLIN AND TAZOBACTAM, NORVASC, MUCOSTA, LANSOPRAZOLE. Patient died on 10/29/2007.

Velcade Side Effects Report #4709485-4
Velcade side effect was reported by a Health Professional from UNITED STATES on June 17, 2005. Male patient, 76 years of age, weighting 208.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood pressure decreased, condition aggravated, dizziness , haematotoxicity, heart rate increased, thrombocytopenia. Velcade dosage: 2.80 MG, INTRAVENOUS. During the same period patient was treated with LEKOVIT CA, FOLIC ACID, COLACE, SENNA, VALTREX, OXYCODONE, PAXIL. Patient recovered.

Velcade Side Effects Report #5689723-4
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 17, 2008. Female patient, 75 years of age, weighting 170.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood cholesterol increased, constipation , convulsion, decreased appetite, diarrhoea, disease recurrence, dysarthria, fall . Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, DEXAMETHASONE, WARFARIN, ACYCLOVIR, BACTRIM, PREVACID, IRON. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5808283-8
Velcade side effect was reported by a Physician from UNITED STATES on June 27, 2008. Female patient, 75 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, blood chloride decreased, bone marrow failure, dizziness , electrolyte imbalance, fatigue, hypokalaemia, hyponatraemia. Velcade dosage: 1.3 MG/M2, IV BOLUS. During the same period patient was treated with PREDNISONE, MELPHALAN, ALPRAZOLAM, ATENOLOL, VERAPAMIL, PREMARIN, MAXZIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4815360-7
Velcade side effect was reported by a Pharmacist from UNITED STATES on Oct 13, 2005. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, international normalised ratio increased, thrombocytopenia. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with ATENOLOL, VEXOL, TIMOPTIC, ALPHAGAN, OLMESARTAN MEDOXOMIL, COUMADIN. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4827759-3
Velcade side effect was reported by a Pharmacist from UNITED STATES on Oct 26, 2005. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, international normalised ratio increased, prothrombin time prolonged, thrombocytopenia, treatment noncompliance. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with WARFARIN, ATENOLOL, TIMOPTIC, ALPHAGAN, OLMESARTAN MEDOXOMIL, COUMADIN, TYLENOL. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #4830543-8
Velcade side effect was reported by a Pharmacist from UNITED STATES on Oct 26, 2005. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, disease progression, international normalised ratio increased, prothrombin time prolonged, thrombocytopenia. Velcade dosage: 1.30 MG/M2, 2/WEEK, INTRAVENOUS. During the same period patient was treated with COUMADIN, ATENOLOL, VEXOL, TIMOPTIC, ALPHAGAN, OLMESARTAN MEDOXOMIL, TYLENOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4832504-1
Velcade side effect was reported by a Pharmacist from UNITED STATES on Nov 03, 2005. Female patient, 75 years of age, weighting 149.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, anaemia, haematocrit decreased, haemoglobin decreased, incorrect dose administered, international normalised ratio increased, prothrombin time prolonged, thrombocytopenia. Velcade dosage: 1.30 MG/M2, UNK, UNK. During the same period patient was treated with WARFARIN, ATENOLOL, TIMOPTIC, ALPHAGAN, OLMESARTAN MEDOXOMIL, ALKA, COUMADIN, TYLENOL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4907779-0
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Jan 24, 2006. Female patient, 75 years of age, weighting 139.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , cardiac enzymes increased, condition aggravated, diarrhoea, fluid overload, haematemesis, hypothermia , melaena. Velcade dosage: 2.10 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with CLODRONATE DI, ALLOPURINOL, AMLODIPINE, LOPERAMIDE, METRONIDAZOLE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4958274-4
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Mar 09, 2006. Female patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac enzymes increased, diarrhoea, haematemesis, hypothermia , malignant neoplasm progression, multiple myeloma , neutropenia, rectal haemorrhage. Velcade dosage: 210 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with CLODRONATE DI, ALLOPURINOL, AMLODIPINE, LOPERAMIDE. Patient died.

Velcade Side Effects Report #4961052-3
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Mar 13, 2006. Female patient, 75 years of age, weighting 139.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , cardiac enzymes increased, diarrhoea, fluid overload, haematemesis, hypothermia , melaena, rectal haemorrhage. Velcade dosage: 2.10 MG, 2/WEEK, INTRAVENOUS. During the same period patient was treated with CLODRONATE DI, ALLOPURINOL, AMLODIPINE, LOPERAMIDE, METRONIDAZOLE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5005828-5
Velcade side effect was reported by a Physician from UNITED STATES on May 01, 2006. Male patient, 75 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, loss of consciousness, nausea , pleural effusion, pulmonary oedema. Velcade dosage: unknown. Patient was hospitalized. Patient died on 01/12/2006.

Velcade Side Effects Report #6029111-4
Velcade side effect was reported by a Physician from JAPAN on Dec 24, 2008. Male patient, 74 years of age, weighting 116.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abasia, anaemia, bacterial infection , c-reactive protein increased, disease progression, hypersensitivity, hypoaesthesia, hypokalaemia, leukopenia. Velcade dosage: 2 MG, INTRAVENOUS. During the same period patient was treated with ADRIAMYCIN PFS, DEXAMETHASONE, AREDIA, MAXIPIME, PLATELETS, POLARAMINE, KYTRIL, LASIX. Patient died on 07/22/2008.

Velcade Side Effects Report #5291322-3
Velcade side effect was reported by a Physician from ITALY on Mar 27, 2007. Female patient, 73 years of age, weighting 143.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: acute prerenal failure, anaemia, bradycardia, electrocardiogram qt prolonged, electrocardiogram t wave inversion, hypokalaemia, hypotension, nausea . Velcade dosage: 2.00 MG, INTRAVENOUS. During the same period patient was treated with THALIDOMIDE, MELPHALAN, PREDNISONE, ALLOPURINOL, ACYCLOVIR, CIPROFLOXACIN, LAMIVUDINE, PLASIL. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5392815-0
Velcade side effect was reported by a Physician from ITALY on July 09, 2007. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, disease progression. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with INSULIN. Patient was hospitalized. Patient died.

Velcade Side Effects Report #5588249-6
Velcade side effect was reported by a Physician from JAPAN on Dec 28, 2007. Male patient, 73 years of age, weighting 158.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, bacterial infection , blood lactate dehydrogenase increased, lung disorder, platelet count decreased. Velcade dosage: 2.3 MG, INTRAVENOUS; 2.20 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE. Patient recovered.


Velcade Side Effects Report #5811426-3
Velcade side effect was reported by a Physician from HUNGARY on July 07, 2008. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, disease progression, multiple myeloma , pneumonia , sepsis , thrombocytopenia. Velcade dosage: 2.3 MG, INTRAVENOUS. During the same period patient was treated with DOXORUBICIN, DEXAMETHASONE. Patient was hospitalized. Patient died.

Velcade Side Effects Report #4701548-2
Velcade side effect was reported by a Physician from on June 13, 2005. Male patient, 73 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anuria, bronchopneumonia, cardiac disorder, condition aggravated, gastrointestinal haemorrhage, hyperkalaemia, hypoglycaemia, hypovolaemic shock. Velcade dosage: 2.10 MG QD INTRAVENOUS. During the same period patient was treated with ALLOPURINOL, ITRACONAZOLE, COTRIMOXAZOL, CLICLAZIDE, METHYLPREDNISOLONE, PANTOPRAZOLE, AMPICILLIN. Patient died on 05/16/2005.

Velcade Side Effects Report #4771197-9
Velcade side effect was reported by a Physician from UNITED STATES on June 15, 2005. Female patient, 73 years of age, weighting 140.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, dizziness , headache , leukopenia, vision blurred, vith nerve paralysis. Velcade dosage: 2.20 MG, IV BOLUS; SEE IMAGE. During the same period patient was treated with DECADRON, PAMIDRONATE DI, LEUKINE, GLUCOPHAGE, ARANESP, ANZEMET. Patient recovered.

Velcade Side Effects Report #5049524-7
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 26, 2006. Male patient, 73 years of age, weighting 192.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5384657-7
Velcade side effect was reported by a Health Professional from UNITED STATES on Dec 14, 2006. Female patient, 72 years of age, weighting 99.87 lb, was diagnosed with multiple myeloma , anaemia and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, hyponatraemia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with ARANESP, ZOMETA. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5714120-2
Velcade side effect was reported by a Physician from JAPAN on Apr 08, 2008. Female patient, 72 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, cardiogenic shock, condition aggravated, diarrhoea, hyperglycaemia, hypoaesthesia, no therapeutic response. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DECADRON. Patient died on 03/21/2008.

Velcade Side Effects Report #5843041-X
Velcade side effect was reported by a Physician from JAPAN on July 29, 2008. Female patient, 72 years of age, weighting 108.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, cardiogenic shock, diarrhoea, hyperglycaemia, hypoaesthesia, platelet count decreased. Velcade dosage: 1.30 MG/M2 UNK INTRAVENOUS. During the same period patient was treated with DECADRON, RED BLOOD CELLS. Patient died on 03/21/2008.

Velcade Side Effects Report #5907654-9
Velcade side effect was reported by a Health Professional from UNITED KINGDOM on Sept 17, 2008. Male patient, 72 years of age, weighting 145.5 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, disease progression, dyspnoea, multiple myeloma , myocardial infarction, neuropathy peripheral, pleural effusion, thrombocytopenia. Velcade dosage: 2.2 MG; 1.6 MG. Patient died on 07/25/2008.

Velcade Side Effects Report #4881255-6
Velcade side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 31, 2005. Female patient, 72 years of age, weighting 151.0 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiac failure congestive, cardiomyopathy , dyspnoea, ejection fraction decreased. Velcade dosage: 1.30 MG/M2. During the same period patient was treated with NORVASC, COREG, LASIX, ANTIARRHYTHMICS, OLMESARTAN MEDOXOMIL, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5246190-2
Velcade side effect was reported by a Physician from JAPAN on Feb 09, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood amylase increased, coagulation time prolonged, hepatic function abnormal, nausea , neuropathy peripheral, orthostatic hypotension, platelet count decreased, urinary retention. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, PREDNISOLONE, LANSOPRAZOLE, BAKTAR, DEPAKENE, ROHYPNOL, MARZULENE S. Patient was hospitalized. Patient recovered.


Velcade Side Effects Report #5261615-4
Velcade side effect was reported by a Physician from JAPAN on Feb 26, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood amylase increased, coagulation time prolonged, hepatic function abnormal, nausea , neuropathy peripheral, orthostatic hypotension, platelet count decreased, urinary retention. Velcade dosage: 1.70 MG, 1.30 MG/M2. During the same period patient was treated with DEXAMETHASONE, PREDNISOLONE, LANSOPRAZOLE, BAKTAR, DEPAKENE, ROHYPNOL, MARZULENE S. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5273283-6
Velcade side effect was reported by a Physician from JAPAN on Mar 07, 2007. Female patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood amylase increased, coagulation time prolonged, dysuria, hepatic function abnormal, hypokalaemia, hypoproteinaemia, muscle atrophy, muscular weakness. Velcade dosage: unknown. During the same period patient was treated with DEXAMETHASONE, PREDNISOLONE, LANSOPRAZOLE, BAKTAR, DEPAKENE, ROHYPNOL, MARZULENE S, LASIX. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5393053-8
Velcade side effect was reported by a Physician from ITALY on July 09, 2007. Male patient, 71 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: activities of daily living impaired, acute pulmonary oedema, anaemia, atrial fibrillation , cardiac failure, discomfort. Velcade dosage: 1.30 MG/M2. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5451071-5
Velcade side effect was reported by a Physician from JAPAN on Aug 30, 2007. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, c-reactive protein increased, cardiac failure, hypotension, pleural effusion. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZOLE, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5489257-6
Velcade side effect was reported by a Physician from UNITED STATES on Oct 05, 2007. Female patient, 71 years of age, weighting 133.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , bacteraemia, cholelithiasis, enteritis, enterococcal infection, hypokalaemia, hypotension, metabolic acidosis. Velcade dosage: 1.00 MG/M2. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5517833-0
Velcade side effect was reported by a Physician from UNITED STATES on Nov 02, 2007. Female patient, 71 years of age, weighting 133.8 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, atrial fibrillation , bacteraemia, cholelithiasis, diarrhoea, enteritis, hypokalaemia, hypotension, metabolic acidosis. Velcade dosage: 1.00 MG/M2 ; 1.00 MG/M2. During the same period patient was treated with DEXAMETHASONE, THALIDOMIDE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5601977-9
Velcade side effect was reported by a Physician from UNITED STATES on Jan 10, 2008. Male patient, 71 years of age, weighting 140.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cachexia, deep vein thrombosis , pain , pleural effusion, pneumonia , pulmonary embolism , thrombocytopenia. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with DOXIL, THALIDOMIDE, ACYCLOVIR, LOMOTIL, ENULOSE, FENTANYL, MEGACE, OXYCODONE. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5634196-0
Velcade side effect was reported by a Physician from JAPAN on Feb 05, 2008. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, diarrhoea, left atrial dilatation, platelet count decreased, pleural effusion, pyrexia, rash , ventricular extrasystoles. Velcade dosage: 1.90 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, MAGNESIUM OXIDE, LENDORM, VALTREX, BIOFERMIN R, DIFLUCAN, MAXIPIME, LEVOFLOXACIN. Patient recovered.

Velcade Side Effects Report #5698787-3
Velcade side effect was reported by a Physician from JAPAN on Mar 24, 2008. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiomegaly, diarrhoea, left atrial dilatation, platelet count decreased, pleural effusion, rash , ventricular extrasystoles. Velcade dosage: 1.9MG, INTRAVENOUS, 1.5 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, MAGNESIUM OXIDE, LENDORM, VALTREX, BIOFERMIN R, DIFLUCAN, MAXIPIME. Patient recovered.

Velcade Side Effects Report #5792550-0
Velcade side effect was reported by a Physician from JAPAN on June 13, 2008. Female patient, 71 years of age, weighting 125.7 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, blood amylase increased, c-reactive protein increased, cardiac failure congestive, coagulation test abnormal, coagulation time prolonged, dehydration, diarrhoea, disease progression. Velcade dosage: 1.70 MG, INTRAVENOUS;20.00 MG INTRAVENOUS; 40.00 MG, INTRAVENOUS; 20.00 MG, INTRAVENOUS. During the same period patient was treated with DEXAMETHASONE, PREDNISOLONE, LANSOPRAZOLE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, DEPAKENE. Patient was hospitalized. Patient died on 05/04/2007.

Velcade Side Effects Report #6026227-3
Velcade side effect was reported by a Physician from JAPAN on Dec 15, 2008. Female patient, 71 years of age, weighting 121.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, cardiomegaly, diarrhoea, left atrial dilatation, pancytopenia, platelet count decreased, pyrexia, rash , ventricular extrasystoles. Velcade dosage: 1.9 MG, INTRAVENOUS ; 1.5 MG, INTRAVENOUS. During the same period patient was treated with ITRACONAZOLE, MAGNESIUM OXIDE, LENDORM, VALTREX, BIOFERMIN R, DIFLUCAN, MAXIPIME. Patient recovered.

Velcade Side Effects Report #6049538-4
Velcade side effect was reported by a Physician from JAPAN on Jan 09, 2009. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arteriosclerosis coronary artery, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, bronchopneumonia, disseminated intravascular coagulation, fungal infection , goitre. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZOLE, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR, THALIDOMIDE. Patient was hospitalized. Patient died on 01/31/2008.

Velcade Side Effects Report #6053881-2
Velcade side effect was reported by a Physician from JAPAN on Jan 15, 2009. Female patient, 71 years of age, weighting 79.37 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, arteriosclerosis coronary artery, blood creatinine increased, blood lactate dehydrogenase increased, blood sodium decreased, blood urea increased, bronchopneumonia, condition aggravated, disseminated intravascular coagulation. Velcade dosage: 1.30 MG/M2, INTRAVENOUS. During the same period patient was treated with LASIX, OMEPRAZON, ALLOPURINOL, SELBEX, ZOLPIDEM TARTRATE, VERAPAMIL HYDROCHLORIDE, TAMBOCOR, THALIDOMIDE. Patient was hospitalized. Patient died.

Velcade Side Effects Report #4616810-1
Velcade side effect was reported by a Health Professional from on Jan 11, 2005. Female patient, 71 years of age, weighting 101.4 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, bone pain, constipation , diarrhoea, gastrointestinal haemorrhage, nausea , productive cough, thrombocytopenia. Velcade dosage: 2.00 MG, IV BOLUS. During the same period patient was treated with ZOFRAN, CHLORIDE, DECADRON, PROCRIT, ZOMETA, POTASSIUM CHLORIDE, MAGNESIUM. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4745525-4
Velcade side effect was reported by a Health Professional from UNITED STATES on July 29, 2005. Female patient, 71 years of age, weighting 105.6 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: abdominal pain , anaemia, blood calcium decreased, bone pain, constipation , diarrhoea, duodenal ulcer, fatigue, gastrointestinal haemorrhage. Velcade dosage: 2.00 MG, IV BOLUS. During the same period patient was treated with ZOFRAN, DECADRON, CHLORIDE, PROCRIT, ZOMETA, POTASSIUM CHLORIDE, MAGNESIUM, DILAUDID. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4769824-5
Velcade side effect was reported by a Physician from UNITED STATES on Aug 03, 2005. Female patient, 71 years of age, weighting 145.9 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anorexia, anxiety , asthenia, buttock pain, depression , disease progression, fatigue, hyponatraemia. Velcade dosage: 2.10 MG, INTRAVENOUS. During the same period patient was treated with DECADRON, AREDIA, PROCRIT, VICOPROFEN, MAVIK, OXYCONTIN, OXYCODONE. Patient recovered.

Velcade Side Effects Report #5259535-4
Velcade side effect was reported by a Physician from UNITED STATES on Feb 22, 2007. Female patient, 70 years of age, weighting 145.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, back pain , blood lactate dehydrogenase increased, burning sensation, disease progression, dry skin, dyspnoea, ecchymosis. Velcade dosage: unknown. During the same period patient was treated with REVLIMID, DEXAMETHASONE, ASPIRIN. Patient recovered.

Velcade Side Effects Report #5460701-3
Velcade side effect was reported by a Physician from RUSSIAN FEDERATION on Sept 10, 2007. Female patient, 70 years of age, weighting 154.3 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: agranulocytosis, anaemia, thrombocytopenia. Velcade dosage: 1.70 MG, INTRAVENOUS. During the same period patient was treated with ETAMSILATE, RECORMON. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #5526144-9
Velcade side effect was reported by a Physician from RUSSIAN FEDERATION on Aug 18, 2007. Male patient, 70 years of age, weighting 152.1 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, bone erosion, compression fracture, hypertension, multiple myeloma , pyrexia. Velcade dosage: 4.00 MG. Patient was hospitalized. Patient died on 12/16/2006.

Velcade Side Effects Report #4769436-3
Velcade side effect was reported by a Physician from UNITED STATES on Aug 10, 2005. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, dyspnoea, lung infiltration, pyrexia. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.

Velcade Side Effects Report #4870761-6
Velcade side effect was reported by a Physician from GERMANY on Dec 14, 2005. Female patient, 70 years of age, weighting 99.21 lb, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, anal haemorrhage, asthenia, cardiac failure, cardiovascular disorder, dyspnoea, lower gastrointestinal haemorrhage, neutropenia. Velcade dosage: 1.60 MG, INTRAVENOUS. Patient was hospitalized. Patient died on 09/26/2005.

Velcade Side Effects Report #4934142-9
Velcade side effect was reported by a Physician from UNITED STATES on Feb 14, 2006. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, atelectasis, biopsy lung abnormal, blood ph increased, cardiac failure congestive, chest x-ray abnormal, cough, dysphonia. Velcade dosage: unknown. Patient was hospitalized and became disabled. Patient recovered.

Velcade Side Effects Report #4992353-0
Velcade side effect was reported by a Physician from UNITED STATES on Feb 14, 2006. Female patient, 70 years of age, was diagnosed with multiple myeloma  and was treated with Velcade. After drug was administered, patient experienced the following side effects: anaemia, asthenia, cough, dysphonia, dyspnoea, hyperhidrosis, lung infiltration, pneumonitis, pyrexia. Velcade dosage: unknown. Patient was hospitalized. Patient recovered.